DBIA
ABBV icon

Dumont & Blake Investment Advisors’s AbbVie ABBV Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-300
Closed -$29K – 190
2017
Q4 		$29K Hold
300
– – 0.01% 185
2017
Q3 		$27K Hold
300
– – 0.01% 185
2017
Q2 		$22K Buy
+300
New +$20.2K 0.01% 187

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dumont & Blake Investment Advisors's ABBV Position: Q1 2026 in Review

Dumont & Blake Investment Advisors reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $46.6K and leaving 13,133 shares worth $2.86M. The position accounts for 0.71% of the portfolio, ranked #35.

Dumont & Blake Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.87M in Q2 2024. 4,082 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Dumont & Blake Investment Advisors held 13,133 shares of AbbVie worth $2.86M as of Q1 2026.
  • Dumont & Blake Investment Advisors sold 210 AbbVie shares in Q1 2026, an estimated $46.6K.
  • AbbVie made up 0.71% of Dumont & Blake Investment Advisors's portfolio in Q1 2026, its #35 holding.
  • Dumont & Blake Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Dumont & Blake Investment Advisors's AbbVie position peaked at $4.87M in Q2 2024.
  • 4,082 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.